Margaret Smith Bell

Insider Reports History

Entity
Individual
Location
C/O Tonix Pharmaceuticals Holding Corp., 509 Madison Ave., Suite 306, New York, NY
Signature
/s/ Jessica Morris, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Margaret Smith Bell:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Tonix Pharmaceuticals Holding Corp. Director Stock Option 105K May 23, 2024 Direct

Insider Reports Filed by Margaret Smith Bell

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TNXP Tonix Pharmaceuticals Holding Corp. May 23, 2024 1 $0 4 May 24, 2024 Director
TNXP Tonix Pharmaceuticals Holding Corp. May 8, 2023 1 $0 4 May 10, 2023 Director
TNXP Tonix Pharmaceuticals Holding Corp. May 9, 2022 1 $0 4 May 11, 2022 Director
TNXP Tonix Pharmaceuticals Holding Corp. May 10, 2021 1 $0 4 May 12, 2021 Director